investor.gidynamics.com investor.gidynamics.com

investor.gidynamics.com

GIDynamics, Inc. - Investors

Skip to main content. GI Dynamics, Inc. Company Overview. GI Dynamics, Inc. (ASX:GID) is the developer of EndoBarrier, the first endoscopically-delivered device approved for the treatment of type 2 diabetes and obesity. EndoBarrier is not approved for sale in the United States and is limited by federal law to investigational use only in the United States. Founded in 2003, GI Dynamics is headquartered in Boston, Massachusetts. Enter the code shown above. Email Alert Sign Up Confirmation. Boston, MA 02210.

http://investor.gidynamics.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTOR.GIDYNAMICS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.4 out of 5 with 13 reviews
5 star
2
4 star
5
3 star
4
2 star
0
1 star
2

Hey there! Start your review of investor.gidynamics.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.7 seconds

FAVICON PREVIEW

  • investor.gidynamics.com

    16x16

  • investor.gidynamics.com

    32x32

  • investor.gidynamics.com

    64x64

  • investor.gidynamics.com

    128x128

CONTACTS AT INVESTOR.GIDYNAMICS.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
GIDynamics, Inc. - Investors | investor.gidynamics.com Reviews
<META>
DESCRIPTION
Skip to main content. GI Dynamics, Inc. Company Overview. GI Dynamics, Inc. (ASX:GID) is the developer of EndoBarrier, the first endoscopically-delivered device approved for the treatment of type 2 diabetes and obesity. EndoBarrier is not approved for sale in the United States and is limited by federal law to investigational use only in the United States. Founded in 2003, GI Dynamics is headquartered in Boston, Massachusetts. Enter the code shown above. Email Alert Sign Up Confirmation. Boston, MA 02210.
<META>
KEYWORDS
1 search toggle
2 who we are
3 management team
4 board of directors
5 scientific advisory board
6 investors
7 overview
8 news and events
9 stock information
10 financial information
CONTENT
Page content here
KEYWORDS ON
PAGE
search toggle,who we are,management team,board of directors,scientific advisory board,investors,overview,news and events,stock information,financial information,corporate governance,investor resources,press,press releases,publications and abstracts,events
SERVER
DOSarrest
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

GIDynamics, Inc. - Investors | investor.gidynamics.com Reviews

https://investor.gidynamics.com

Skip to main content. GI Dynamics, Inc. Company Overview. GI Dynamics, Inc. (ASX:GID) is the developer of EndoBarrier, the first endoscopically-delivered device approved for the treatment of type 2 diabetes and obesity. EndoBarrier is not approved for sale in the United States and is limited by federal law to investigational use only in the United States. Founded in 2003, GI Dynamics is headquartered in Boston, Massachusetts. Enter the code shown above. Email Alert Sign Up Confirmation. Boston, MA 02210.

LINKS TO THIS WEBSITE

gidynamics.com gidynamics.com

EndoBarrier

http://www.gidynamics.com/endobarrier-overview.php

Type 2 Diabetes and Obesity. Clinical data suggest that treatment with EndoBarrier Therapy affects key gastrointestinal hormones involved in insulin sensitivity, glucose metabolism, satiety and food intake. Additionally, in clinical studies, EndoBarrier Therapy has also been shown to improve cardiometabolic risks. To learn more about the EndoBarrier please visit www.endobarrier.com. Type 2 Diabetes and Obesity.

UPGRADE TO PREMIUM TO VIEW 22 MORE

TOTAL LINKS TO THIS WEBSITE

23

OTHER SITES

investor.genovis.com investor.genovis.com

Genovis Investor Relations » Investor Relations

Fem år i sammandrag. Val av styrelse / valberedning. Ändr: -0.04 (-1.44%) / Köp: 2.73 / Sälj: 2.77 / Senast: 2.73 / Högst: 2.75 / Lägst: 2.71 / Antal: 14920 / Oms.: 40656 / Valuta: SEK / 2017-01-13 16:51 (CET). GENOVIS BYTER CERTIFIED ADVISER. Genovis har tecknat licensavtal med Life Technologies Corporation. Genovis och Promega har ingått förlikning och tecknat ett globalt licensavtal. ÖKAD FÖRSÄLJNING OCH KRAFTIGT FÖRBÄTTRAT RESULTAT. HALVÅRSRAPPORT JANUARI JUNI 2016. Tel: 46 46 10 12 30.

investor.genworth.com investor.genworth.com

Genworth Financial - Investors

Stock Quote and Chart. Stock Purchase / Dividend Reinvestment. Dividends and Stock Splits. Code of Business Conduct and Ethics. Political Contributions and Expenditures. 2017 Annual Meeting Of Stockholders Results. 2017 Special Meeting Of Stockholders Results. Welcome to Genworth Investor Relations. Genworth remains committed to helping families become more financially secure, self-reliant and prepared for the future. Genworth 4Q17 Earning Summary Presentation (Feb 7). View all press releases.

investor.genworth.com.au investor.genworth.com.au

Genworth - Investor Centre

About Genworth and LMI. What is Lenders Mortgage Insurance? How can Lenders Mortgage Insurance benefit me? Lenders Mortgage Insurance FAQs. Lenders Mortgage Insurance endorsements. Partnership and Distribution team. Genworth in the community. Investor and international news. MFAA National Convention 2015. Share price and tools. Share price and graph. Online tools, forms and reports. LMI Proposal and Variation Requests. Homeowner Assistance Program (HOAP). Policy and process information. How to sell LMI.

investor.genworthmicanada.ca investor.genworthmicanada.ca

Genworth MI Canada - Home

Feb 7, 2018 10:30 AM ET. Q4 REPORT NOW AVAILABLE. December 6, 2017. Annual General Meeting of Shareholders. June 8, 2017 10:00am ET. Education and Financial Literacy. Community and Civic Responsibility. Compensation and Nominating Committee. Risk, Capital and Investment Committee. PANEL 1: Driving Core Growth. PANEL 2: Proactively Mitigating Risk. PANEL 3: Sustaining Profitability. March 5, 2018 -. National Meaning of Home youth writing contest raises $170,000 for Habitat for Humanity. February 6, 2018 -.

investor.ggp.com investor.ggp.com

GGP Investor Center

Kiosks, Carts and Specialty Leasing. GGP in the Community. Properties keyboard arrow right. Leasing keyboard arrow right. Kiosks, Carts and Specialty Leasing. Advertising keyboard arrow right. Investors keyboard arrow right. About GGP keyboard arrow right. GGP in the Community. GGP’s mission is to own and operate best-in-class retail properties that provide an outstanding environment and experience for our communities, retailers, employees, consumers and shareholders. View our latest Investor Presentation.

investor.gidynamics.com investor.gidynamics.com

GIDynamics, Inc. - Investors

Skip to main content. GI Dynamics, Inc. Company Overview. GI Dynamics, Inc. (ASX:GID) is the developer of EndoBarrier, the first endoscopically-delivered device approved for the treatment of type 2 diabetes and obesity. EndoBarrier is not approved for sale in the United States and is limited by federal law to investigational use only in the United States. Founded in 2003, GI Dynamics is headquartered in Boston, Massachusetts. Enter the code shown above. Email Alert Sign Up Confirmation. Boston, MA 02210.

investor.gigatronics.com investor.gigatronics.com

Giga-tronics Incorporated (GIGA)

Advanced Signal Generator Module. Advanced Signal Analyzer Module. Real-Time Threat Emulation System. Advanced Signal Control Software Suite. Consider Build vs Buy your next EW / Radar test system? Call us 1 925 328 4650. Advanced Signal Generator Module. Advanced Signal Analyzer Module. Real-Time Threat Emulation System. Advanced Signal Control Software Suite. Feb 12, 2018 4:02 PM EST. Q3 2018 Quarterly Results. Quarter Ended Dec 30, 2017. Mar 26, 2018. Quarter Ended Dec 30, 2017. View Board of Directors.

investor.gingeroil.se investor.gingeroil.se

Finansiell info | Ginger Oil

Prenumerera på nyheter och rapporter. Här erbjuder vi aktieägare, analytiker och investerare kontinuerlig finansiell information. Vi strävar efter en öppen dialog och transparens gentemot aktieägare, investerare, analytiker, kunder och media. Genom vår IR-kontakt kan du få svar på frågor som rör vår finansiella information eller bolagsstyrning. Lyckad hedgning av oljepriset. Läs mer om hedgningen och prisnivåer i pressmeddelandet. Nasdaq Stockholm First North. Utdelning på Ginger Oils Preferensaktier.

investor.gk-software.com investor.gk-software.com

IR GK Software

Dynamisches Wachstum durch innovative Lösungen für den Einzelhandel. GK Software AG - XETRA. Equity, ISIN DE0007571424, WKN 757142. Unsere Aktie an der Börse. GK Software AG steigert Umsatz im ersten Quartal um rund 40 Prozent. Die GK SOFTWARE AG hat in den ersten drei Monaten des Geschäftsjahres 2015 ihren Umsatz um 3,65 Mio. Euro auf 12,98 Mio. Euro gesteigert (Q1 2014: 9,33…. Ad-hoc-Mitteilung: GK Software AG steigert nach vorläufigen Zahlen im Geschäftsjahr 2014 den Umsatz um 5 Prozent. Die GK SOFTWA...

investor.glbsm.com investor.glbsm.com

Globe Specialty Metals, Inc. - Investor Relations

World Leader in Silicon Metal and Specialty Alloys. Jul 13, 2015. Globe Specialty Metals and Grupo FerroAtlantica Announce Leadership Positions in Connection With Planned Combination. May 6, 2015. Globe Specialty Metals Reports Increased Earnings and Margin Expansion in Third Quarter Fiscal 2015; Preliminary Proxy Statement/Prospectus on Form F-4 Filed Today in Connection With the Proposed Business Combination With Ferro-Atlantica. Apr 30, 2015. Feb 23, 2015. View all releases ».

investor.gldd.com investor.gldd.com

Investors | Great Lakes Dredge & Dock Corporation

Trailing Suction Hopper Dredges. Rivers & Lakes Dredges. Ports & Harbors. GLDD In The News. Before & After Transformations. Annual Reports and Proxies. Trailing Suction Hopper Dredges. Rivers & Lakes Dredges. Ports & Harbors. GLDD In The News. Before & After Transformations. Annual Reports and Proxies. Feb 20, 2018. Great Lakes Reports Year-End Results Including $29.5m Charge for Restructuring Costs; Confirms Savings Initiatives on Track. Feb 14, 2018. View all press releases ». Feb 20, 2018 at 9:00 AM CT.